Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000167918 | SCV000218566 | pathogenic | Hereditary spastic paraplegia 4 | 2018-07-03 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with glutamic acid at codon 546 of the SPAST protein (p.Gly546Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. This variant has been observed to be de novo in an individual affected with hereditary spastic paraplegia (PMID: Invitae). The observation of one or more missense substitutions at this codon (p.Gly546Glu and p.Gly546Arg) in affected individuals suggests that this may be a clinically significant residue (PMID: 27260292, Invitae). For these reasons, this variant has been classified as Pathogenic. This missense change is located within a functionally conserved AAA domain of the SPAST protein (PMID: 9695811, 18410514) and a high percentage (~85%) of previously reported SPAST missense mutations have been found within this domain (PMID: 18701882). These observations suggest that a novel missense substitution within this domain may affect protein function, but experiments have not been done to test this possibility. |